Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. Radhakrishnan A, Wallner LP, Skolarus TA, George AK, et al. J Urol 2022 May 6:101097JU0000000000002734. doi: 10.1097/JU.0000000000002734.

Read + Share

Amedeo Smart

Independent Medical Education

Radhakrishnan A, Wallner LP, Skolarus TA, George AK, et al. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. J Urol 2022 May 6:101097JU0000000000002734. doi: 10.1097/JU.0000000000002734.
PMID: 35522191